Archived: VIRTUAL TRAINING EVENT | Drug Discovery Safety Assessment for Chemists

General Principles, Impact of Drug Properties

Date: 26 May - 27 May 2020

Location: On-Line Event

Tutors: Dr Bryan H. Norman

This is a VIRTUAL short course that will look at the unexpected safety risks that arise during nearly every drug discovery effort.  

May 26,  3.00 – 4.30 pm (UK)  |  Session 1

May 27,  3.00 – 4.30 pm (UK) |  Session 2

This short course will explore the general principles of preclinical safety assessment, with particular emphasis on actions that can be taken by chemists to mitigate safety risks in new drug candidates.  Based on drug attrition analyses and regulatory guidance, best practices for the use of in silico, in vitro and in vivo methods of predictive toxicology will be presented.  More specific details on the risks associated with drug properties, such as lipophilicity, will be highlighted.

When you register you will be sent links to join the on-line sessions. These will take place at the following time each day:

Who should attend this on line course:

This course is specifically designed for chemists.  Other members of cross-functional drug discovery teams, such as toxicologists, biologists, pharmacologists, pharmacokineticists and program managers may also gain valuable insights from the content.

3.00 – 5.00 pm  |  UK

4.00 – 6.00 pm  |  Central Europe

10.00 – 12.00 |  Eastern US

6.00 – 8.00 am  |  West Coast US

As space is limited there is a small charge of £95.00 + VAT* per person (*only added if your company is based in the UK) Payments only available via credit card.

Testimonials

Virtual Delegate 2020

I really enjoyed the virtual Short Course and it was very good incl. the thorough collection of examples etc.

Looking forward to the next ones!